I agree that this site is using cookies. You can find further informations here.
X
Facheris, Maurizio F.
80  results:
Search for persons X
?
1

Continuous subcutaneous foslevodopa/foscarbidopa infusion f..:

Fung, Victor S.C. ; Aldred, Jason ; Arroyo, Martha P....
Clinical Parkinsonism & Related Disorders.  10 (2024)  - p. 100239 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Improved Sleep Correlates with Improved Quality of Life and..:

Chaudhuri, K. Ray ; Facheris, Maurizio F. ; Bergmans, Bruno...
Movement Disorders Clinical Practice.  11 (2024)  7 - p. 861-866 , 2024
Link: https://doi.org/10.1002/..
 
?
3

Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkins..:

Aldred, Jason ; Freire-Alvarez, Eric ; Amelin, Alexander V....
Neurology and Therapy.  12 (2023)  6 - p. 1937-1958 , 2023
Link: https://doi.org/10.1007/..
 
?
4

Correction: Continuous SubcutaneousFoslevodopa/Foscarbidopa..:

Aldred, Jason ; Freire-Alvarez, Eric ; Amelin, Alexander V....
Neurology and Therapy.  12 (2023)  6 - p. 1959-1960 , 2023
Link: https://doi.org/10.1007/..
 
?
5

Foslevodopa/foscarbidopa subcutaneous infusion maintains eq..:

Rosebraugh, Matthew ; Stodtmann, Sven ; Liu, Wei.
Parkinsonism & Related Disorders.  97 (2022)  - p. 68-72 , 2022
Link: https://doi.org/10.1016/..
 
?
6

Foslevodopa/Foscarbidopa Is Well Tolerated and Maintains St..:

Rosebraugh, Matthew ; Liu, Wei ; Neenan, Melina.
Journal of Parkinson's Disease.  11 (2021)  4 - p. 1695-1702 , 2021
Link: https://doi.org/10.3233/..
 
?
7

Foslevodopa/Foscarbidopa: A New Subcutaneous Treatment for ..:

Rosebraugh, Matthew ; Voight, Eric A. ; Moussa, Ehab M....
Annals of Neurology.  90 (2021)  1 - p. 52-61 , 2021
Link: https://doi.org/10.1002/..
 
?
8

Long‐term safety and efficacy of levodopa‐carbidopa intesti..:

Fernandez, Hubert H. ; Boyd, James T. ; Fung, Victor S. C....
Movement Disorders.  33 (2018)  6 - p. 928-936 , 2018
Link: https://doi.org/10.1002/..
 
?
9

Safety and efficacy of levodopa-carbidopa intestinal gel: r..:

Murata, Miho ; Mihara, Masahito ; Hasegawa, Kazuko...
Therapeutic Advances in Neurological Disorders.  11 (2018)  - p. 175628641875931 , 2018
Link: https://doi.org/10.1177/..
 
?
10

Effect of Levodopa‐carbidopa Intestinal Gel on Non‐motor Sy..:

Standaert, David G. ; Rodriguez, Ramon L. ; Slevin, John T....
Movement Disorders Clinical Practice.  4 (2017)  6 - p. 829-837 , 2017
Link: https://doi.org/10.1002/..
 
?
11

Plasma and White Blood Cells Show Different miRNA Expressio..:

Schwienbacher, Christine ; Foco, Luisa ; Picard, Anne...
Journal of Molecular Neuroscience.  62 (2017)  2 - p. 244-254 , 2017
Link: https://doi.org/10.1007/..
 
?
12

Deregulation of miRNAs 103a, 30b and 29a in peripheral bloo..:

Serafin, Alice ; Foco, Luisa ; Zanigni, Stefano...
Parkinsonism & Related Disorders.  22 (2016)  - p. e189-e190 , 2016
Link: https://doi.org/10.1016/..
 
?
13

Motor and nonmotor heterogeneity of LRRK2‐related and idiop..:

Marras, Connie ; Alcalay, Roy N. ; Caspell‐Garcia, Chelsea...
Movement Disorders.  31 (2016)  8 - p. 1192-1202 , 2016
Link: https://doi.org/10.1002/..
 
?
14

The Cooperative Health Research in South Tyrol (CHRIS) stud..:

Pattaro, Cristian ; Gögele, Martin ; Mascalzoni, Deborah...
Journal of Translational Medicine.  13 (2015)  1 - p. , 2015
Link: https://doi.org/10.1186/..
 
?
15

Overexpression of blood microRNAs 103a, 30b, and 29a inl-do..:

Serafin, Alice ; Foco, Luisa ; Zanigni, Stefano...
Neurology.  84 (2015)  7 - p. 645-653 , 2015
Link: https://doi.org/10.1212/..
 
1-15